🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Treatment Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and assertions of next-day UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, doctors and chemists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering substances of unknown origin.

Several experts said the popularity for the experimental drug could be connected to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach medicines, advertising, and consumer laws, potentially leading to fines, prosecution or prison.

Platform Reaction and Content Removal

According to the social media company, the service has removed problematic material and banned related hashtags and query recommendations. The company said it was dedicated to keeping the platform safe and investing in strengthening compliance measures.

Online Trading Activities

Investigations also discovered groups with up to nine thousand participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, filled with photos of slimming results, glowing testimonials and step-by-step instructions for mixing or administering at residence.

Within minutes of joining one community, a seller posted WhatsApp details, where most transactions take place. The vendor sent an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, health issues or past usage.

Item Information and Pricing

Within these groups, posts show dark colored parcels with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service said it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering materials they can’t verify. Although the research behind this drug is valid, these digital products may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has already seen individuals injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These substances could be impure or improperly measured.”

Producer Position

A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational product not yet authorized … may expose users to potentially serious medical dangers”.